Health
FDA mandates new warning labels for GLP-1 drugs over rare eye condition
The FDA is requiring manufacturers of GLP-1 medications to add warnings about a rare eye condition that may lead to permanent vision loss.
Tuesday, 10 November 2026
Trending Now
Massive fire as Israeli settlers burn down business near NablusGlobal Banks Secure $270 Million for Project Faro Stablecoin InitiativeFire Contained on Platform in Iran's South Pars Gas FieldEric Zemmour Announces Second Bid for French PresidencyWashington State Sees Growth in Businesses Accepting Bitcoin PaymentsRussia Expels Moldovan Diplomat Amid Tensions Over Drone DebrisHIVE Digital Eyes $45 Million in Annual Revenue From Sweden AI CenterThomas Markle Jailed After Cutting Ankle MonitorMassive fire as Israeli settlers burn down business near NablusGlobal Banks Secure $270 Million for Project Faro Stablecoin InitiativeFire Contained on Platform in Iran's South Pars Gas FieldEric Zemmour Announces Second Bid for French PresidencyWashington State Sees Growth in Businesses Accepting Bitcoin PaymentsRussia Expels Moldovan Diplomat Amid Tensions Over Drone DebrisHIVE Digital Eyes $45 Million in Annual Revenue From Sweden AI CenterThomas Markle Jailed After Cutting Ankle Monitor